Melodic Distribution Company (MDC) will seek international distribution for PreHistin within its network throughout Europe, Australia and Asia. MDC has received very strong indications of interest from its
Under the second tranche of the private placement, the company issued 1.33 million common shares at a price of $1.25 per common share. The common shares issued pursuant
Premacure intends to initiate a Phase II multicenter trial for Iplex in the retinopathy of prematurity indication during the second quarter of 2009. With an orphan designation in
Levetiracetam oral solution is available in the 100mg/ml strength and is the generic equivalent of Keppra oral solution by UCB. Levetiracetam oral solution is used in the treatment
The upfront payment represents the total payment for bevirimat and will be expensed by Myriad Genetics during its third fiscal quarter ending March 31, 2009. Myriad Pharmaceuticals has
The board of directors has appointed Sonny Young to the role of vice president of finance and treasurer, effective January 1, 2009. Mr West will remain with the
The acquired Medivices technology involves designing, marketing and manufacturing new innovative medical devices using nanomedicine and Micro-ElectroMechanical Systems. The acquisition includes all patent and proprietary rights and property
Patrick Balthrop, president and CEO of Luminex, said: “On behalf of the board of directors, employees and shareholders, I would like to thank Doug for his leadership, hard
According to Vein Clinics of America (VCA), the Ohio office represents its 33rd location in the US and offers the latest in vein disease diagnosis and treatment. Ted
Andrew Whelan, CEO of BioElectronics, said: “This is significant news for BioElectronics. We were already seeing strong success with London drugs in Western Canada and we have recently
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.